Results

1–5 of 5 results for anti-vascular endothelial growth factor

Intravitreal Therapeutics Utilization in 2023
Anton M Kolomeyer, MD, PhD
Annual Meeting Talks
2024
Conversion Rates from Nonexudative to Exudative Age-Related Macular Degeneration: An AAO IRIS® Registry Analysis
Dan A Gong, MD
Annual Meeting Talks
2022
Cognitive Testing in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Wet Age-Related Macular Degeneration
Subhransu K. Ray, MD, PhD
Annual Meeting Talks
2020
Current Practice Preferences and Antisepsis Protocols for Intravitreal Anti-vascular Endothelial Growth Factor Injections
David Xu, MD
On Demand Cases, Courses, and Papers
2019
Visual Acuity Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Retinal Vein Occlusion in Routine Clinical Practice
Yasha S Modi, MD
On Demand Cases, Courses, and Papers
2019